Lumos Pharma, Inc.

LUMO · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$13,519$16,799$23,179$35,078
Short-Term Investments$0$0$0$999
Receivables$174$168$181$210
Inventory$0$0$0$0
Other Curr. Assets$3,581$3,925$4,184$3,748
Total Curr. Assets$17,274$20,892$27,544$40,035
Property Plant & Equip (Net)$187$463$534$603
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$187$463$534$603
Other Assets$0$0$0$0
Total Assets$17,461$21,355$28,078$40,638
Liabilities
Payables$1,455$337$569$890
Short-Term Debt$130$608$293$564
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,920$3,990$3,552$5,576
Total Curr. Liab.$6,505$4,935$4,414$7,030
LT Debt$42$145$225$303
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,000$6,000$6,000$6,000
Total NC Liab.$6,042$6,145$6,225$6,303
Other Liabilities$0$0$0$0
Cap. Leases$172$449$518$585
Total Liabilities$12,547$11,080$10,639$13,333
Equity
Pref Stock$0$0$0$0
Common Stock$86$81$81$81
Retained Earnings-$186,976-$179,509-$171,958-$161,517
AOCI$0-$0$0-$0
Other Equity$191,804$189,703$189,316$188,741
Total Equity$4,914$10,275$17,439$27,305
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$17,461$21,355$28,078$40,638
Net Debt-$13,347-$16,046-$22,661-$34,211
Lumos Pharma, Inc. (LUMO) Financial Statements & Key Stats | AlphaPilot